All posts by: Michael Zand

About Michael Zand

Building the Safe Genes Toolkit – R & D Magazine

Continue reading

2017-07-20 NEWS

R & D Magazine

Building the Safe Genes Toolkit
R & D Magazine
Such chemicals could propel the development of therapeutic applications of genome editors by limiting off-target effects or protect against future biological threats. The team will also construct synthetic genome editors for precision genome engineering.

and more »

Continue reading

2017-07-20 NEWS

Phys.Org

Library of CRISPR targeting sequences increases power of the gene-editing method
Phys.Org
CRISPR-Cas9 is a reprogrammable DNA cutting machine that is being used to edit genomes in many organisms for research purposes. Its primary component, the Cas9 enzyme (orange), cuts genomic DNA (blue). The enzyme is directed to its …more.
Researchers Design, Construct Genome-Wide Sequence-Verified Arrayed CRISPR LibraryGenomeWeb

all 3 news articles »

Continue reading

2017-07-20 NEWS

Phys.Org

Library of CRISPR targeting sequences increases power of the gene-editing method
Phys.Org
CRISPR-Cas9 is a reprogrammable DNA cutting machine that is being used to edit genomes in many organisms for research purposes. Its primary component, the Cas9 enzyme (orange), cuts genomic DNA (blue). The enzyme is directed to its …more.
Researchers Design, Construct Genome-Wide Sequence-Verified Arrayed CRISPR LibraryGenomeWeb

all 3 news articles »

Continue reading

2017-07-20 NEWS

Medical Xpress

Innate reaction of hematopoietic stem cells to severe infections
Medical Xpress
Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide—that is, without signals from growth factors. This direct production of defensive cells damages …

and more »

Continue reading

2017-07-20 NEWS

Technology Networks

CRISPR Reveals New Targets for Promising Cancer Drugs
Technology Networks
redit: Haining Lab, Dana-Farber/Boston Children’s Genetic screening for cancer immunotherapy targets cancer cells (colored shapes), each with a different CRISPR-Cas9-mediated gene knocked out. T cells (red) destroy the cancer cells that have had …

and more »